Breaking News Instant updates and real-time market news.

CANF

Can-Fite BioPharma

$2.15 /

-0.045 (-2.05%)

14:52
02/10/20
02/10
14:52
02/10/20
14:52

Can-Fite BioPharma prices 3.33M units at $1.50 per unit

Can-Fite BioPharma announced the pricing of a public offering of 3.33M units at a price to the public of $1.50 per unit. The company expects to receive aggregate gross proceeds of approximately $5.0M, before deducting the placement agent fees and estimated offering expenses. Each unit is comprised of one American Depositary Share and one warrant to purchase one ADS at an exercise price of $1.50 per ADS. H.C. Wainwright is acting as the exclusive placement agent for the offering, which is expected to close on or about February 12.

  • 16

    Feb

CANF Can-Fite BioPharma
$2.15 /

-0.045 (-2.05%)

10/31/19 H.C. Wainwright
Can-Fite BioPharma price target raised to $5 from $3 at H.C. Wainwright
03/27/19 H.C. Wainwright
Can-Fite selloff yesterday on trial miss unwarranted, says H.C. Wainwright

TODAY'S FREE FLY STORIES

Hot Stocks
Oxford Lane sees NAV $2.87-$2.97 as of May 31 » 08:11
06/04/20
06/04
08:11
06/04/20
08:11
OXLC

Oxford Lane

$4.81 /

+0.13 (+2.78%)

Oxford Lane Capital…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OXLC Oxford Lane
$4.81 /

+0.13 (+2.78%)

OXLC Oxford Lane
$4.81 /

+0.13 (+2.78%)

OXLC Oxford Lane
$4.81 /

+0.13 (+2.78%)

Conference/Events
FDA PDUFA Date for Merck RECARBRIO is June 4, 2020  08:10
06/04/20
06/04
08:10
06/04/20
08:10
MRK

Merck

$82.07 /

+1.22 (+1.51%)

 
ShowHide Related Items >><<
MRK Merck
$82.07 /

+1.22 (+1.51%)

MRK Merck
$82.07 /

+1.22 (+1.51%)

06/03/20 Alliance Global Partners
OpGen, NYS DOH collaboration extension 'highly positive,' says Alliance Global
06/02/20 JPMorgan
JPMorgan positions for second half with three picks in Major Pharma
05/27/20 Alliance Global Partners
PDS Biotechnology initiated with a Buy at Alliance Global Partners
05/20/20 JonesTrading
Merck collaboration positions Surface Oncology well, says JonesTrading
MRK Merck
$82.07 /

+1.22 (+1.51%)

MRK Merck
$82.07 /

+1.22 (+1.51%)

MRK Merck
$82.07 /

+1.22 (+1.51%)

MRK Merck
$82.07 /

+1.22 (+1.51%)

Recommendations
K12 price target raised to $32 from $30 at BMO Capital » 08:10
06/04/20
06/04
08:10
06/04/20
08:10
LRN

K12

$26.04 /

+0.09 (+0.35%)

BMO Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LRN K12
$26.04 /

+0.09 (+0.35%)

LRN K12
$26.04 /

+0.09 (+0.35%)

01/28/20 Barrington
K12 price target lowered to $30 from $40 at Barrington
01/28/20 BMO Capital
K12 price target lowered to $23 from $27 at BMO Capital
08/13/19 William Blair
William Blair starts Chegg, K12 with Outperform ratings
08/12/19 William Blair
K12 initiated with an Outperform at William Blair
LRN K12
$26.04 /

+0.09 (+0.35%)

LRN K12
$26.04 /

+0.09 (+0.35%)

Recommendations
Autodesk price target raised to $250 from $240 at Wells Fargo » 08:10
06/04/20
06/04
08:10
06/04/20
08:10
ADSK

Autodesk

$226.18 /

+7.205 (+3.29%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ADSK Autodesk
$226.18 /

+7.205 (+3.29%)

ADSK Autodesk
$226.18 /

+7.205 (+3.29%)

07:33 Today Credit Suisse
Autodesk price target raised to $240 from $225 at Credit Suisse
06:49 Today Mizuho
Autodesk price target raised to $250 from $225 at Mizuho
06:25 Today Barclays
Autodesk price target raised to $250 from $230 at Barclays
04:51 Today Stifel
Autodesk price target raised to $245 from $210 at Stifel
ADSK Autodesk
$226.18 /

+7.205 (+3.29%)

ADSK Autodesk
$226.18 /

+7.205 (+3.29%)

ADSK Autodesk
$226.18 /

+7.205 (+3.29%)

ADSK Autodesk
$226.18 /

+7.205 (+3.29%)

Hot Stocks
CHF Solutions says CHKD launches ultrafiltration therapy using Aquadex SmartFlow » 08:09
06/04/20
06/04
08:09
06/04/20
08:09
CHFS

CHF Solutions

$0.37 /

+0.0068 (+1.90%)

CHF Solutions announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CHFS CHF Solutions
$0.37 /

+0.0068 (+1.90%)

CHFS CHF Solutions
$0.37 /

+0.0068 (+1.90%)

Recommendations
nVent Electric price target raised to $29 from $26 at Rosenblatt » 08:09
06/04/20
06/04
08:09
06/04/20
08:09
NVT

nVent Electric

$19.62 /

+0.73 (+3.86%)

Rosenblatt analyst Scott…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NVT nVent Electric
$19.62 /

+0.73 (+3.86%)

NVT nVent Electric
$19.62 /

+0.73 (+3.86%)

02/18/20 RBC Capital
nVent Electric upgraded to Outperform from Sector Perform at RBC Capital
02/18/20 RBC Capital
nVent Electric upgraded to Outperform from Sector Perform at RBC Capital
02/06/20 Barclays
nVent Electric upgraded to Overweight from Equal Weight at Barclays
12/10/19 CL King
nVent Electric initiated with a Neutral at CL King
NVT nVent Electric
$19.62 /

+0.73 (+3.86%)

NVT nVent Electric
$19.62 /

+0.73 (+3.86%)

Recommendations
Xylem price target raised to $70 from $63 at Rosenblatt » 08:09
06/04/20
06/04
08:09
06/04/20
08:09
XYL

Xylem

$70.03 /

+2.17 (+3.20%)

Rosenblatt analyst Scott…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XYL Xylem
$70.03 /

+2.17 (+3.20%)

XYL Xylem
$70.03 /

+2.17 (+3.20%)

05/15/20 Vertical Research
Xylem upgraded to Hold from Sell at Vertical Research
05/07/20 Cowen
Xylem price target lowered to $50 from $65 at Cowen
04/16/20 Vertical Research
Xylem downgraded to Sell from Hold at Vertical Research
04/08/20 Goldman Sachs
Xylem downgraded to Sell from Neutral at Goldman Sachs
XYL Xylem
$70.03 /

+2.17 (+3.20%)

Hot Stocks
Aldeyra reaches agreement with FDA to use RASP as treatment sign for DED » 08:09
06/04/20
06/04
08:09
06/04/20
08:09
ALDX

Aldeyra

$4.65 /

-0.3 (-6.06%)

Aldeyra announced that,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALDX Aldeyra
$4.65 /

-0.3 (-6.06%)

ALDX Aldeyra
$4.65 /

-0.3 (-6.06%)

05/11/20 Oppenheimer
Aldeyra initiated with an Outperform at Oppenheimer
12/03/19 JonesTrading
Aldeyra dry eye data positive nearly across the board, says JonesTrading
10/22/19 Cantor Fitzgerald
Aldeyra assumed with an Overweight at Cantor Fitzgerald
10/14/19 Roth Capital
Ophthalmic therapies 'could go from 0 to 100 real quick,' says Roth Capital
ALDX Aldeyra
$4.65 /

-0.3 (-6.06%)

ALDX Aldeyra
$4.65 /

-0.3 (-6.06%)

Hot Stocks
Potbelly reduces cash burn by 75%, says cash-neutral at store-level as of May 31 » 08:07
06/04/20
06/04
08:07
06/04/20
08:07
PBPB

Potbelly

$2.28 /

+0.05 (+2.24%)

Potbelly Corporation…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PBPB Potbelly
$2.28 /

+0.05 (+2.24%)

PBPB Potbelly
$2.28 /

+0.05 (+2.24%)

12/11/19 Piper Jaffray
Potbelly downgraded to Neutral from Overweight at Piper Jaffray
PBPB Potbelly
$2.28 /

+0.05 (+2.24%)

PBPB Potbelly
$2.28 /

+0.05 (+2.24%)

PBPB Potbelly
$2.28 /

+0.05 (+2.24%)

Recommendations
Elastic price target raised to $95 from $90 at Oppenheimer » 08:07
06/04/20
06/04
08:07
06/04/20
08:07
ESTC

Elastic

$89.23 /

+0.41 (+0.46%)

Oppenheimer analyst Ittai…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ESTC Elastic
$89.23 /

+0.41 (+0.46%)

ESTC Elastic
$89.23 /

+0.41 (+0.46%)

06:26 Today Barclays
Elastic price target raised to $108 from $70 at Barclays
06:13 Today Piper Sandler
Elastic price target raised to $94 from $66 at Piper Sandler
05:04 Today Jefferies
Jefferies boosts Elastic target to $105, says buy on earnings pullback
06/01/20 RBC Capital
Elastic price target raised to $95 from $85 at RBC Capital
ESTC Elastic
$89.23 /

+0.41 (+0.46%)

ESTC Elastic
$89.23 /

+0.41 (+0.46%)

ESTC Elastic
$89.23 /

+0.41 (+0.46%)

Hot Stocks
DelMar Pharmaceuticals' VAL-083 selected for global GBM pivotal study » 08:07
06/04/20
06/04
08:07
06/04/20
08:07
DMPI

DelMar Pharmaceuticals

$0.81 /

-0.0069 (-0.85%)

DelMar Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DMPI DelMar Pharmaceuticals
$0.81 /

-0.0069 (-0.85%)

DMPI DelMar Pharmaceuticals
$0.81 /

-0.0069 (-0.85%)

09/06/19 Maxim
DelMar Pharmaceuticals initiated with a Buy at Maxim
DMPI DelMar Pharmaceuticals
$0.81 /

-0.0069 (-0.85%)

Recommendations
Roku weakness on new TCL TVs 'well overdone,' says Rosenblatt » 08:06
06/04/20
06/04
08:06
06/04/20
08:06
ROKU

Roku

$103.93 /

-6.895 (-6.22%)

Rosenblatt analyst Mark…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ROKU Roku
$103.93 /

-6.895 (-6.22%)

ROKU Roku
$103.93 /

-6.895 (-6.22%)

06/03/20 Stephens
Roku may be seeing pressure from Best Buy TCL TVs, says Stephens
06/03/20 SunTrust
New TVs at Best Buy present 'modest' new competition for Roku, says Suntrust
05/22/20
Fly Intel: Top five analyst downgrades
05/22/20 Stephens
Roku downgraded to Equal Weight on worries about TCL at Stephens
ROKU Roku
$103.93 /

-6.895 (-6.22%)

ROKU Roku
$103.93 /

-6.895 (-6.22%)

ROKU Roku
$103.93 /

-6.895 (-6.22%)

ROKU Roku
$103.93 /

-6.895 (-6.22%)

Initiation
RNC Minerals initiated with a Buy at Stifel GMP » 08:05
06/04/20
06/04
08:05
06/04/20
08:05
RNKLF

RNC Minerals

$0.00 /

+ (+0.00%)

Stifel GMP analyst Ian…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
    Earnings
    Mohawk Group raises 2020 net revenue view $170M-$180M from $165M-$175M » 08:04
    06/04/20
    06/04
    08:04
    06/04/20
    08:04
    MWK

    Mohawk Group

    $4.78 /

    -0.04 (-0.83%)

    Consensus $168.48M. For…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    MWK Mohawk Group
    $4.78 /

    -0.04 (-0.83%)

    MWK Mohawk Group
    $4.78 /

    -0.04 (-0.83%)

    03/09/20 Roth Capital
    Mohawk Group resumed with a Buy at Roth Capital
    12/20/19
    Fly Intel: Top five analyst initiations
    12/20/19 DA Davidson
    Mohawk Group initiated with a Buy at DA Davidson
    07/11/19 National Securities
    Mohawk Group initiated with a Buy at National Securities
    MWK Mohawk Group
    $4.78 /

    -0.04 (-0.83%)

    MWK Mohawk Group
    $4.78 /

    -0.04 (-0.83%)

    Upgrade
    Sally Beauty upgraded to Outperform at Oppenheimer » 08:04
    06/04/20
    06/04
    08:04
    06/04/20
    08:04
    SBH

    Sally Beauty

    $15.21 /

    +1.415 (+10.26%)

    As previously reported,…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    SBH Sally Beauty
    $15.21 /

    +1.415 (+10.26%)

    SBH Sally Beauty
    $15.21 /

    +1.415 (+10.26%)

    05:34 Today Oppenheimer
    Sally Beauty upgraded to Outperform from Perform at Oppenheimer
    04/27/20 DA Davidson
    Sally Beauty price target lowered to $10 from $14.50 at DA Davidson
    04/20/20 Raymond James
    Sally Beauty preliminary Q2 not as bad as feared, says Raymond James
    01/21/20 DA Davidson
    Sally Beauty upgraded to Neutral from Underperform at DA Davidson
    SBH Sally Beauty
    $15.21 /

    +1.415 (+10.26%)

    Hot Stocks
    Mohawk Group reports preliminary May net revenue increased approx. 105% » 08:03
    06/04/20
    06/04
    08:03
    06/04/20
    08:03
    MWK

    Mohawk Group

    $4.78 /

    -0.04 (-0.83%)

    Mohawk Group Holdings…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    MWK Mohawk Group
    $4.78 /

    -0.04 (-0.83%)

    MWK Mohawk Group
    $4.78 /

    -0.04 (-0.83%)

    03/09/20 Roth Capital
    Mohawk Group resumed with a Buy at Roth Capital
    12/20/19
    Fly Intel: Top five analyst initiations
    12/20/19 DA Davidson
    Mohawk Group initiated with a Buy at DA Davidson
    07/11/19 National Securities
    Mohawk Group initiated with a Buy at National Securities
    MWK Mohawk Group
    $4.78 /

    -0.04 (-0.83%)

    MWK Mohawk Group
    $4.78 /

    -0.04 (-0.83%)

    Hot Stocks
    Mylan and Lupin granted marketing authorization for Nepexto in Europe » 08:03
    06/04/20
    06/04
    08:03
    06/04/20
    08:03
    MYL

    Mylan

    $17.54 /

    +0.08 (+0.46%)

    Mylan and Lupin announced…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    MYL Mylan
    $17.54 /

    +0.08 (+0.46%)

    MYL Mylan
    $17.54 /

    +0.08 (+0.46%)

    03/25/20 Cantor Fitzgerald
    Few concerns weighing on Mylan shares today, says Cantor Fitzgerald
    02/06/20 BMO Capital
    Biogen price target raised to $317 from $297 at BMO Capital
    02/05/20 Baird
    Biogen price target raised to $290 from $250 at Baird
    02/05/20 Mizuho
    Biogen's Tecfidera win worth $15-$30 per share to DCF, Mizuho says
    MYL Mylan
    $17.54 /

    +0.08 (+0.46%)

    MYL Mylan
    $17.54 /

    +0.08 (+0.46%)

    MYL Mylan
    $17.54 /

    +0.08 (+0.46%)

    MYL Mylan
    $17.54 /

    +0.08 (+0.46%)

    Hot Stocks
    Jounce Therapeutics regains worldwide rights to JTX-8064 from Bristol-Myers » 08:02
    06/04/20
    06/04
    08:02
    06/04/20
    08:02
    JNCE

    Jounce Therapeutics

    $5.62 /

    +0.1 (+1.81%)

    , BMY

    Bristol-Myers

    $60.21 /

    -0.45 (-0.74%)

    Jounce Therapeutics…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    JNCE Jounce Therapeutics
    $5.62 /

    +0.1 (+1.81%)

    BMY Bristol-Myers
    $60.21 /

    -0.45 (-0.74%)

    JNCE Jounce Therapeutics
    $5.62 /

    +0.1 (+1.81%)

    05/07/20 H.C. Wainwright
    Jounce Therapeutics price target lowered to $8 from $10 at H.C. Wainwright
    03/25/20 Raymond James
    Jounce upgraded to Strong Buy ahead of cancer data at Raymond James
    03/25/20 Raymond James
    Jounce Therapeutics upgraded to Strong Buy from Outperform at Raymond James
    BMY Bristol-Myers
    $60.21 /

    -0.45 (-0.74%)

    06/02/20 Credit Suisse
    Arena Pharmaceuticals price target raised to $87 from $77 at Credit Suisse
    06/02/20 Cantor Fitzgerald
    Arena Pharmaceuticals price target raised to $88 from $68 at Cantor Fitzgerald
    06/02/20 Oppenheimer
    Ayala Pharmaceuticals initiated with an Outperform at Oppenheimer
    05/13/20 Stifel
    Bluebird's ide-cel remains approvable despite FDA's 'strict stance,' says Stifel
    JNCE Jounce Therapeutics
    $5.62 /

    +0.1 (+1.81%)

    BMY Bristol-Myers
    $60.21 /

    -0.45 (-0.74%)

    BMY Bristol-Myers
    $60.21 /

    -0.45 (-0.74%)

    BMY Bristol-Myers
    $60.21 /

    -0.45 (-0.74%)

    BMY Bristol-Myers
    $60.21 /

    -0.45 (-0.74%)

    Hot Stocks
    Qualigen Therapeutics receives Notice of Allowance for U.S. patent » 08:01
    06/04/20
    06/04
    08:01
    06/04/20
    08:01
    QLGN

    Qualigen Therapeutics

    $5.00 /

    -0.58 (-10.39%)

    Qualigen Therapeutics…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    QLGN Qualigen Therapeutics
    $5.00 /

    -0.58 (-10.39%)

    Recommendations
    Inovio, Novavax COVID vaccines should not be disregarded, says Cantor » 08:00
    06/04/20
    06/04
    08:00
    06/04/20
    08:00
    INO

    Inovio

    $12.43 /

    -1.94 (-13.50%)

    , NVAX

    Novavax

    $44.26 /

    -5.31 (-10.71%)

    Although "broad and…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    INO Inovio
    $12.43 /

    -1.94 (-13.50%)

    NVAX Novavax
    $44.26 /

    -5.31 (-10.71%)

    INO Inovio
    $12.43 /

    -1.94 (-13.50%)

    06/01/20 Piper Sandler
    Context 'may be necessary' for Inovio's INO-5401 GBM update, says Piper Sandler
    05/21/20 Benchmark
    Inovio initiated with a Buy at Benchmark
    05/20/20 Roth Capital
    Most of Inovio COVID-19 vaccine data 'over two months old,' says Roth Capital
    05/20/20 Piper Sandler
    Piper Sandler stays Neutral on Inovio, offers a 'little perspective' on vaccine
    NVAX Novavax
    $44.26 /

    -5.31 (-10.71%)

    06/03/20 B. Riley FBR
    Novavax selloff on 'Warp Speed' report unwarranted, says B. Riley FBR
    05/26/20 B. Riley FBR
    Novavax has become a leading COVID vaccine candidate, says B. Riley FBR
    05/18/20 B. Riley FBR
    Novavax price target raised to $53 from $43 at B. Riley FBR
    05/14/20 Ladenburg
    Novavax price target raised to $50 from $38 at Ladenburg
    INO Inovio
    $12.43 /

    -1.94 (-13.50%)

    NVAX Novavax
    $44.26 /

    -5.31 (-10.71%)

    INO Inovio
    $12.43 /

    -1.94 (-13.50%)

    NVAX Novavax
    $44.26 /

    -5.31 (-10.71%)

    INO Inovio
    $12.43 /

    -1.94 (-13.50%)

    NVAX Novavax
    $44.26 /

    -5.31 (-10.71%)

    INO Inovio
    $12.43 /

    -1.94 (-13.50%)

    NVAX Novavax
    $44.26 /

    -5.31 (-10.71%)

    Recommendations
    General Dynamics price target raised to $184 from $167 at Susquehanna » 08:00
    06/04/20
    06/04
    08:00
    06/04/20
    08:00
    GD

    General Dynamics

    $155.22 /

    +6.03 (+4.04%)

    Susquehanna analyst…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    GD General Dynamics
    $155.22 /

    +6.03 (+4.04%)

    GD General Dynamics
    $155.22 /

    +6.03 (+4.04%)

    05/20/20 RBC Capital
    RBC Capital starts General Dynamics at Outperform on sub 'dominance'
    05/20/20 RBC Capital
    General Dynamics initiated with an Outperform at RBC Capital
    05/19/20 Seaport Global
    Seaport Global starts 'underappreciated' General Dynamics at Buy
    05/19/20 Seaport Global
    General Dynamics initiated with a Buy at Seaport Global
    GD General Dynamics
    $155.22 /

    +6.03 (+4.04%)

    GD General Dynamics
    $155.22 /

    +6.03 (+4.04%)

    GD General Dynamics
    $155.22 /

    +6.03 (+4.04%)

    GD General Dynamics
    $155.22 /

    +6.03 (+4.04%)

    Options
    Scientific Games call buyer realizes 4% same-day gains » 08:00
    06/04/20
    06/04
    08:00
    06/04/20
    08:00
    SGMS

    Scientific Games

    $18.62 /

    +2.38 (+14.66%)

    Notable profits for the…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    SGMS Scientific Games
    $18.62 /

    +2.38 (+14.66%)

    SGMS Scientific Games
    $18.62 /

    +2.38 (+14.66%)

    05/21/20 Credit Suisse
    Scientific Games assumed with an Underperform at Credit Suisse
    04/16/20 Jefferies
    Gaming equipment suppliers 'managing around' fortunes of casinos, says Jefferies
    04/15/20 Craig-Hallum
    Scientific Games price target lowered to $20 from $55 at Craig-Hallum
    02/20/20 Deutsche Bank
    Scientific Games price target lowered to $23 from $29 at Deutsche Bank
    SGMS Scientific Games
    $18.62 /

    +2.38 (+14.66%)

    SGMS Scientific Games
    $18.62 /

    +2.38 (+14.66%)

    SGMS Scientific Games
    $18.62 /

    +2.38 (+14.66%)

    SGMS Scientific Games
    $18.62 /

    +2.38 (+14.66%)

    Upgrade
    Sykes Enterprises upgraded to Outperform at Baird » 07:58
    06/04/20
    06/04
    07:58
    06/04/20
    07:58
    SYKE

    Sykes Enterprises

    $28.61 /

    +1.04 (+3.77%)

    As reported previously,…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    SYKE Sykes Enterprises
    $28.61 /

    +1.04 (+3.77%)

    05:17 Today Baird
    Sykes Enterprises upgraded to Outperform from Neutral at Baird
    03/16/20 Sidoti
    Sykes Enterprises upgraded to Buy from Neutral at Sidoti
    11/11/19 Sidoti
    Sykes Enterprises downgraded to Neutral on valuation at Sidoti
    Recommendations
    Occidental Petroleum severance plan could drive sale speculation, says KeyBanc » 07:57
    06/04/20
    06/04
    07:57
    06/04/20
    07:57
    OXY

    Occidental Petroleum

    $15.44 /

    +0.695 (+4.71%)

    KeyBanc analyst Leo…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    OXY Occidental Petroleum
    $15.44 /

    +0.695 (+4.71%)

    OXY Occidental Petroleum
    $15.44 /

    +0.695 (+4.71%)

    06:57 Today Wolfe Research
    Occidental Petroleum downgraded to Underperform from Peer Perform at Wolfe Research
    06/01/20 Scotiabank
    Scotiabank upgrades 'relative winner' Pioneer Natural to Outperform
    06/01/20 Scotiabank
    Scotiabank downgrades Occidental to Sector Perform on 'new reality'
    06/01/20 Scotiabank
    Occidental Petroleum downgraded to Sector Perform from Outperform at Scotiabank
    OXY Occidental Petroleum
    $15.44 /

    +0.695 (+4.71%)

    OXY Occidental Petroleum
    $15.44 /

    +0.695 (+4.71%)

    OXY Occidental Petroleum
    $15.44 /

    +0.695 (+4.71%)

    OXY Occidental Petroleum
    $15.44 /

    +0.695 (+4.71%)

    Recommendations
    Planet Fitness price target raised to $82 from $65 at Baird » 07:55
    06/04/20
    06/04
    07:55
    06/04/20
    07:55
    PLNT

    Planet Fitness

    $77.36 /

    +3.43 (+4.64%)

    Baird analyst Jonathan…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    PLNT Planet Fitness
    $77.36 /

    +3.43 (+4.64%)

    PLNT Planet Fitness
    $77.36 /

    +3.43 (+4.64%)

    07:41 Today Raymond James
    Raymond James cuts Planet Fitness to Market Perform on 'stretched' valuation
    07:28 Today Cowen
    Planet Fitness price target raised to $80 from $65 at Cowen
    04:48 Today Raymond James
    Planet Fitness downgraded to Market Perform from Outperform at Raymond James
    06/03/20 DA Davidson
    Planet Fitness price target raised to $86 from $70 at DA Davidson
    PLNT Planet Fitness
    $77.36 /

    +3.43 (+4.64%)

    PLNT Planet Fitness
    $77.36 /

    +3.43 (+4.64%)

    PLNT Planet Fitness
    $77.36 /

    +3.43 (+4.64%)

    PLNT Planet Fitness
    $77.36 /

    +3.43 (+4.64%)

    Get Full Fly Access

    Breaking market intelligence sent straight to you
    Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
    Up-to-date information on important industry events
    Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
    News focused on the companies in your portfolio
    Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.